Discover the story behind our beginnings and vision for the future.
Putnam has been a leader in life science consulting for over 30 years. We’re an Inizio Advisory company, known within our ecosystem for helping our clients make confident, impactful decisions.
Today, our comprehensive suite of services across commercial, value, pricing, and access, and medical and scientific affairs are supporting our firm’s mission and our clients’ success.
What started as a small but mighty consulting group has grown into a leading scientific and strategic consulting partner with:
At Putnam, our global team of rigorously trained and highly engaged scientists and strategists dig deep to solve your most complex challenges and advance your innovations.
Who we are
Putnam, an Inizio Advisory company, is a leading scientific and strategic consulting partner that helps the global life science community make confident, impactful decisions and develop bespoke solutions that support bringing life-changing innovations to clinicians and patients.
For more than 30 years, we’ve taken a client-centric approach uniquely combining our strategic mindset and global cross-functional capabilities to deliver unrivaled depth across therapeutic areas, healthcare sectors, and technology platforms to maximize the human impact and commercial success of client innovations.
Putnam bridges the highest levels of scientific and strategic excellence across the product development and commercialization lifecycle. We offer a breadth and depth of capabilities across areas.
We help you navigate complexities and develop bold strategies with centers of excellence in advanced clinical technologies, financial modeling and forecasting, and integrated insights.
Inizio Advisory is a trusted advisor for health and life science companies that leverages connected solutions and intelligence to turn science into strategy and execution for every stage of the journey from early commercialization to product launch and beyond.
Get the latest insights and perspectives from our experts.
Insights from the 13th CMO Summit: Expanding CMO roles, early Medical Affairs integration, and innovation in clinical trials.
Explore key themes from MAPS Americas 2025—advancing health equity, AI, and collaboration in Medical Affairs.
Explore MedAffairs 2025 insights: AI, omnichannel strategy & impact driving pharma success and better patient outcomes.
Putnam is pleased to welcome Simon Pannett as Partner within our HTA and Market Access team.